Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Quigg

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Australian Nurses' Journal. Royal Australian Nursing Federation|July 1, 1992
Melbourne AIDS vigilS Braithwaite, R Quigg
Urology|March 1, 1983
Retroperitoneal bleeding: hidden culprit of acute renal failureM S Weinberg, R Quigg, R L Krane
American Heart Journal|September 15, 1998
Impaired exercise capacity late after cardiac transplantation: influence of chronotropic incompetence, hypertension, and calcium channel blockersR Quigg, J Salyer, P K Mohanty, et al.
Pacing and Clinical Electrophysiology : PACE|April 6, 2000
Defibrillators in nonischemic cardiomyopathy treatment evaluationA Kadish, R Quigg, A Schaechter, et al.
Journal of the American College of Cardiology|July 14, 2001
Relation of thallium uptake to morphologic features of chronic ischemic heart disease: evidence for myocardial remodeling in noninfarcted myocardiumJ Shirani, J Lee, R Quigg, et al.
European Journal of Applied Physiology|November 4, 2010
Exercise-associated hyponatremia: the influence of pre-exercise carbohydrate status combined with high volume fluid intake on sodium concentrations and fluid balanceKimberly A Hubing, John T Bassett, Laura R Quigg, et al.
Health Education Research|March 24, 2017
Changes in awareness of cancer risk factors among adult New Zealanders (CAANZ): 2001 to 2015R Richards, B McNoe, E Iosua, et al.
Journal of the American College of Cardiology|June 1, 1996
Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trailS C Brozena, M R Johnson, H Ventura, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Australian Nurses' Journal. Royal Australian Nursing Federation|July 1, 1992
Melbourne AIDS vigilS Braithwaite, R Quigg
Urology|March 1, 1983
Retroperitoneal bleeding: hidden culprit of acute renal failureM S Weinberg, R Quigg, R L Krane
American Heart Journal|September 15, 1998
Impaired exercise capacity late after cardiac transplantation: influence of chronotropic incompetence, hypertension, and calcium channel blockersR Quigg, J Salyer, P K Mohanty, et al.
Pacing and Clinical Electrophysiology : PACE|April 6, 2000
Defibrillators in nonischemic cardiomyopathy treatment evaluationA Kadish, R Quigg, A Schaechter, et al.
Journal of the American College of Cardiology|July 14, 2001
Relation of thallium uptake to morphologic features of chronic ischemic heart disease: evidence for myocardial remodeling in noninfarcted myocardiumJ Shirani, J Lee, R Quigg, et al.
European Journal of Applied Physiology|November 4, 2010
Exercise-associated hyponatremia: the influence of pre-exercise carbohydrate status combined with high volume fluid intake on sodium concentrations and fluid balanceKimberly A Hubing, John T Bassett, Laura R Quigg, et al.
Health Education Research|March 24, 2017
Changes in awareness of cancer risk factors among adult New Zealanders (CAANZ): 2001 to 2015R Richards, B McNoe, E Iosua, et al.
Journal of the American College of Cardiology|June 1, 1996
Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trailS C Brozena, M R Johnson, H Ventura, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
Pageof 1